AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
19
Employees19
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
19
Employees19

AIM Key Statistics

Market cap
5.65M
Market cap5.65M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
20.71M
Average volume20.71M
High today
$0.5877
High today$0.5877
Low today
$0.385
Low today$0.385
Open price
$0.4323
Open price$0.4323
Volume
29.66M
Volume29.66M
52 Week high
$20.35
52 Week high$20.35
52 Week low
$0.21
52 Week low$0.21

Stock Snapshot

As of today, AIM ImmunoTech(AIM) shares are valued at $0.39. The company's market cap stands at 5.65M, with a P/E ratio of -0.05.

On 2026-06-16, AIM ImmunoTech(AIM) stock moved within a range of $0.39 to $0.59. With shares now at $0.39, the stock is trading +2.3% above its intraday low and -33.0% below the session's peak.

Trading activity shows a volume of 29.66M, compared to an average daily volume of 20.71M.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.21.

Over the past 52 weeks, AIM ImmunoTech(AIM) stock has traded between a high of $20.35 and a low of $0.21.

AIM News

TipRanks 16h
AIM ImmunoTech Regains NYSE American Listing Compliance

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

Investing.com 7d
AIM ImmunoTech raises $2.65M in direct offering - Investing.com

...

AIM ImmunoTech raises $2.65M in direct offering - Investing.com
TipRanks 7d
AIM ImmunoTech announces $2.65M registered direct offering

AIM ImmunoTech (AIM) announced that it has entered into definitive agreements for a registered direct offering and concurrent private placement priced at-the-ma...

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.